- Home
- PLX vs NEXM Comparison
PLX vs NEXM Comparison
Compare PLX & NEXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- NEXM
- Stock Information
- Founded
- PLX 1993
- NEXM N/A
- Country
- PLX United States
- NEXM Canada
- Employees
- PLX N/A
- NEXM N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- NEXM
- Sector
- PLX Health Care
- NEXM
- Exchange
- PLX Nasdaq
- NEXM Nasdaq
- Market Cap
- PLX 127.4M
- NEXM 130.4M
- IPO Year
- PLX 1998
- NEXM N/A
- Fundamental
- Price
- PLX $1.91
- NEXM $5.95
- Analyst Decision
- PLX Strong Buy
- NEXM
- Analyst Count
- PLX 1
- NEXM 0
- Target Price
- PLX $15.00
- NEXM N/A
- AVG Volume (30 Days)
- PLX 705.4K
- NEXM 66.5K
- Earning Date
- PLX 11-13-2025
- NEXM 08-13-2025
- Dividend Yield
- PLX N/A
- NEXM N/A
- EPS Growth
- PLX N/A
- NEXM N/A
- EPS
- PLX 0.08
- NEXM N/A
- Revenue
- PLX $61,948,000.00
- NEXM N/A
- Revenue This Year
- PLX $14.53
- NEXM N/A
- Revenue Next Year
- PLX $75.77
- NEXM N/A
- P/E Ratio
- PLX $24.60
- NEXM N/A
- Revenue Growth
- PLX 62.79
- NEXM N/A
- 52 Week Low
- PLX $0.99
- NEXM $4.82
- 52 Week High
- PLX $3.10
- NEXM $10.35
- Technical
- Relative Strength Index (RSI)
- PLX 70.20
- NEXM N/A
- Support Level
- PLX $1.52
- NEXM N/A
- Resistance Level
- PLX $1.69
- NEXM N/A
- Average True Range (ATR)
- PLX 0.08
- NEXM 0.00
- MACD
- PLX 0.03
- NEXM 0.00
- Stochastic Oscillator
- PLX 91.67
- NEXM 0.00
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About NEXM NexMetals Mining Corp. Common Shares
NexMetals Mining Corp is a mineral exploration and development company focused on discovering and advancing high-quality copper-nickel-cobalt-platinum element metals (Cu- Cu-Ni-Co-PGE) resources. The group prioritizes projects in stable, mining-friendly jurisdictions with supportive foreign investment and rule-of-law standards. Its projects are Botswana and Canada.